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Bacterial cell growth necessitates synthesis of peptidogly-
can. Assembly of this major constituent of the bacterial cell
wall is a multistep process starting in the cytoplasm and
ending in the exterior cell surface. The intracellular part of
the pathway results in the production of the membrane-
anchored cell wall precursor, Lipid II. After synthesis this
lipid intermediate is translocated across the cell membrane.
The translocation (ﬂipping) step of Lipid II was demon-
strated to require a speciﬁc protein (ﬂippase). Here, we
show that the integral membrane protein FtsW, an essential
protein of the bacterial division machinery, is a transporter
of the lipid-linked peptidoglycan precursors across the
cytoplasmic membrane. Using Escherichia coli membrane
vesicles we found that transport of Lipid II requires the
presence of FtsW, and puriﬁed FtsW induced the transbi-
layer movement of Lipid II in model membranes. This study
provides the ﬁrst biochemical evidence for the involvement
of an essential protein in the transport of lipid-linked cell
wall precursors across biogenic membranes.
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Introduction
The cell wall or peptidoglycan layer is unique and essential to
bacteria. Most steps involved in its biosynthesis are therefore
exploited as targets for well-known antibiotics or are explored
for designing novel drugs. The central events in the building of
peptidoglycan enclose the synthesis of two lipid intermediates
on the cytoplasmic side of the membrane, Lipid I and Lipid II,
and the subsequent transport of the latter across the bacterial
membrane. In brief, the cytoplasmic step of peptidoglycan
precursor synthesis culminates in the production of
UDP-N-acetylmuramyl-pentapeptide (UDP-MurNAc-pentapep-
tide) from UDP-N-acetyl-glucosamine (UDP-GlcNAc). This
compound is coupled to undecaprenyl phosphate to form
Lipid I by MraY, an integral membrane protein. The subsequent
addition of GlcNAc by MurG, an enzyme associated with the
membrane, yields Lipid II (its structure is illustrated in
Figure 1A). Thereafter, Lipid II is translocated to the exterior
surface of the cell by an unknown mechanism and incorpo-
rated into the peptidoglycan through transglycosylation and
transpeptidation reactions by penicillin-binding proteins (PBPs;
Ho ¨ltje, 1998; Cabeen and Jacobs-Wagner, 2007; Bouhss et al,
2008; den Blaauwen et al, 2008; Vollmer and Bertsche, 2008).
The molecular and cellular details of the transport of
peptidoglycan subunits across the cytoplasmic membrane
are as yet unidentiﬁed. Recently, the translocation process
was studied in Escherichia coli inner membrane vesicles using
a ﬂuorescent 7-nitro-2,1,3-benzoxadiazol-4-yl (NBD) analo-
gue of Lipid II (van Dam et al, 2007; its structure is illustrated
in Figure 1B). The transport machinery was shown not to be
dependent on metabolic energy, but was demonstrated to be
protein facilitated. To date, no speciﬁc proteins have been
identiﬁed yet. Potential transporters (ﬂippases) are predicted
to be inner membrane proteins, essential and conserved in
most eubacteria producing peptidoglycan cell wall. On the
basis of these characteristics and its effects on peptidoglycan
synthesis, FtsW has been suggested to act as a ﬂippase
decades ago (Matsuhashi, 1994; Ho ¨ltje, 1998). FtsW is an
essential division protein with 10 predicted transmembrane
segments and belongs to the SEDS (shape, elongation, divi-
sion and sporulation) family, which includes RodA and
SpoVE proteins. At least one member of the SEDS family
appears to be present in all bacteria that have a peptidoglycan
cell wall. RodA, FtsWand Bacillus subtilis SpoVE are thought
to participate in separate peptidoglycan synthesis complexes
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1425acting during elongation, division and sporulation, respec-
tively. Within these complexes, each protein from the SEDS
family is accompanied by its cognate PBP. For example,
FtsWand PBP3 (FtsI) are important during division, whereas
RodA and PBP2 operate speciﬁcally during the elongation
step of rod-shaped bacteria. The gene encoding FtsW is
located on the dcw (division and cell wall) cluster in close
proximity to the gene encoding PBP3. FtsW was shown to be
localized to the septum during division in E. coli and to
interact with PBP3 (Boyle et al, 1997; Mercer and Weiss,
2002; Pastoret et al, 2004; Fraipont et al, 2011), thereby
connecting the cell wall synthesis and the division machin-
ery. More interestingly, the gene encoding FtsW is always
located next to that encoding MurG, which suggests that they
interact.
Altogether, these considerations support the old specula-
tion that FtsW could act as Lipid II transporter, implying that
RodA and SpoVE fulﬁl these roles during elongation and
sporulation, respectively.
Results
A FRET-based assay to study Lipid II translocation
To address the role of FtsW in the ﬂipping process, we
developed a novel ﬂuorescence resonance energy transfer
(FRET)-based assay to study the translocation of the mem-
brane-anchored cell wall precursor Lipid II in bacterial mem-
brane vesicles. This assay makes use of the speciﬁc
recognition of Lipid II by vancomycin (Breukink and de
Kruijff, 2006) and the inability of this antibiotic to cross the
membrane. Using NBD-labelled Lipid II as a donor and
tetramethylrhodamine cadaverine (TMR)-labelled vancomy-
cin as an acceptor of the ﬂuorescence, a strong FRET signal
(a ﬂuorescence signal yielded by the energy transfer between
NBD and TMR ﬂuorophores when they are in close proxi-
mity) is detectable only when Lipid II is present (Figure 2).
This FRET signal is absent when the ﬂuorescence of NBD-
Lipid II that is located in the outer leaﬂet of the vesicles has
been quenched beforehand by the membrane impermeant
reductant dithionite (Supplementary Figure S1).
We then assessed if this FRETapproach would be suitable
to assay Lipid II transport in right-side-out (RSO) membrane
vesicles prepared from E. coli cells. The assay is based on the
synthesis of NBD-labelled Lipid II at the inner leaﬂet of RSOs,
which will be translocated across the membrane to appear
at the outer leaﬂet rendering it accessible to vancomycin
(see the hypothetical plot in Supplementary Figure S2, right
panel). The appearance of Lipid II at the outer leaﬂet and
concomitant binding to TMR-labelled vancomycin will lead to
a decrease in the NBD ﬂuorescence, which will be accom-
panied by an increase of TMR ﬂuorescence (Supplementary
Figure S2, left panel). In the RSOs, synthesis of ﬂuorescently
labelled Lipid II was enabled by following a freeze–thaw
procedure to introduce the precursors NBD-UDP-MurNAc-
pentapeptide and UDP-GlcNAc into the lumen of the vesicles.
When RSO vesicles derived from wild-type E. coli prepared in
this way were incubated at 141C (All FRET measurements
were carried out at 141C to prevent the decrease in the
ﬂuorescence of NBD-labelled Lipid II in time at elevated
temperatures resulting from transglycosylase activity, most
likely of PBPs as reported on earlier in van Dam et al (2007).
This decrease leads to a reduction in the total ﬂuorescence of
the FRET signal when measurements are performed at tem-
peratures around 251C.) in the presence of vancomycin-TMR,
an increase in the ﬂuorescence of the latter accompanied by a
decrease in the NBD ﬂuorescence was detected (Figure 3A).
This gradual increase in the FRET signal reﬂects the appear-
ance of Lipid II on the outside of the vesicles, demonstrating
that the assay is capable of measuring Lipid II transport in
bacterial membranes. Upon overexpression of FtsW in the
same E. coli strain, the translocation of Lipid II was consider-
ably increased (Figure 3B). This indicates that FtsW is
involved in the transit of Lipid II from the inner to the
outer leaﬂet of the membrane. Enhanced translocation
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Figure 1 Schematic representation of the chemical structure of
Lipid II (A) and NBD-labelled Lipid II (B). This peptidoglycan
precursor consists of an undecaprenyl chain, phosphate (Pi),
MurNAc (M) and GlcNAc (G). The pentapeptide moiety of
MurNAc is symbolized by circles. NBD ﬂuorophore is attached at
the lysine of the pentapeptide moiety residue.
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Figure 2 The interaction between ﬂuorescently labelled vancomy-
cin and Lipid II leads to FRET. In this assay, NBD-Lipid II (labelled at
the amino group of the lysine at position 3 of the pentapeptide) and
vancomycin-TMR (labelled at its C terminus with tetramethylrho-
damine cadaverine) are used as a FRET pair. Fluorescence spectra of
NBD-Lipid II (in LUVs prepared as described in Materials and
methods) and vancomycin-TMR separately and together are pre-
sented (while being exited at the wavelength of the NBD group).
The energy transfer between NBD and TMR ﬂuorophores yields a
ﬂuorescence signal when they are in close proximity of each other.
This is generally reﬂected by a decrease in ﬂuorescence of NBD-
Lipid II and increase in ﬂuorescence of vancomycin-TMR. A.U.:
arbitrary units.
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NBD-Lipid II was monitored using membrane vesicles de-
rived from cells overexpressing Streptococcus pneumoniae
FtsW (Supplementary Figure S3), which signiﬁes that the
effect of FtsW is species independent. Overexpression of
other (control) proteins did not result in an augmentation
of Lipid II translocation (Supplementary Figure S4A–C).
To further probe the role of FtsW in Lipid II translocation,
we determined the transport of Lipid II in bacterial mem-
branes depleted of FtsW. For this we isolated membranes
from an FtsW depletion strain of E. coli (Boyle et al, 1997).
While Lipid II transport in RSOs prepared from this strain
(under conditions that allow expression of FtsW) was similar
to that in RSOs derived from the wild-type strain (compare
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Figure 3 Expression of FtsW increases the translocation of NBD-
Lipid II from the inner to the outer leaﬂet of the bacterial mem-
brane. Generation of a FRETsignal was monitored over time in RSO
vesicles prepared from wild-type TOP10F’ strain (A), and TOP10F’
harbouring a plasmid encoding His-tagged FtsW, where the expres-
sion of the ftsW gene is under the control of an IPTG-inducible
promoter (B). The time course of ﬂuorescence was monitored
during 30min. Assaying the wild-type strain yielded a gradual
increase in the FRET signal in time (A). Overexpression of the
ftsW gene causes a signiﬁcant increase in the FRET signal (B).
Background signals obtained from RSO vesicles, where neither
NBD-UDP-MurNAc-pentapeptide nor UDP-GlcNAc were incorpo-
rated and were subtracted from each measurement. Synthesis of
NBD-Lipid II in the vesicles was monitored using TLC. All measure-
ments are representative of at least three independent experiments.
A.U.: arbitrary units. (C) The time course of the FRET signal in
(A) and (B) displayed as a 578/534 ratio, where 578nm is the
emission maximum of vancomycin-TMR and 534nm is the emis-
sion maximum of NBD-Lipid II. Error bars represent s.d. of the
mean value of the ratios measured at 578±5 and 534±5nm.
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Figure 4 The translocation of NBD-Lipid II across the bacterial
membrane is affected by the depletion of FtsW. The LMC1436 strain
(FtsW depletion strain) was grown in the presence of arabinose to
induce the expression of FtsW, and RSO vesicles were prepared as
described before. These behaved similarly as the wild-type E. coli
strains in yielding a moderate augmentation in ﬂuorescence in time
(A). When this strain was grown in the presence of glucose
(inducing the depletion of FtsW), a reduced FRET signal (reﬂecting
a reduced Lipid II translocation) is obtained (B) compared with that
where the expression of FtsW was induced. The ﬂuorescence
spectra in (B) were normalized to the same scale as in (A). All
measurements are representative of at least three independent
experiments. A.U: arbitrary units. (C) The time course of the
FRET signal in (A) and (B) displayed as a 578/534 ratio,
where 578nm is the emission maximum of vancomycin-TMR and
534nm is the emission maximum of NBD-Lipid II. Error bars
represent s.d. of the mean value of the ratios measured at 578±5
and 534±5nm.
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Lipid II transport (Figure 4B and C). This implies that the
translocation of NBD-Lipid II requires the presence of FtsW.
The remaining observed transport activity is likely due to the
presence of the FtsW homologue, RodA.
FtsW is directly involved in the transport of Lipid II
To demonstrate whether FtsW is directly involved in Lipid II
transport, we puriﬁed E. coli FtsW (Figure 5A) and tested its
effect on the topology of Lipid II in model membranes using
a dithionite reduction assay (McIntyre and Sleight, 1991;
Kol et al, 2001) adapted to determine the topology of Lipid
II (van Dam et al, 2007). To this end, FtsW was reconstituted
in large unilamellar vesicles (LUVs) with NBD-Lipid II. In
these proteoliposomes (with a diameter of B150nm) NBD-
Lipid II is symmetrically distributed between the inner and
outer leaﬂets. As illustrated in Figure 5B, LUVs reconstituted
in the absence of protein demonstrate a reduction of B50%
of the ﬂuorescence signal of NBD-Lipid II upon addition of
dithionite. This corresponds to the quenching of NBD-Lipid II
pool residing in the outer leaﬂet of the LUVs. The remaining
50% is localized to the inner leaﬂet of the LUVs and is
protected from quenching by the membrane impermeant
reductant. When 0.1% Triton X-100 was added to permeabi-
lize the vesicles, complete quenching of all ﬂuorescence was
achieved.
We assayed several control proteins for their effect on Lipid
II topology. Among these KcsA, MraY and SecYEG, KcsA is
the potassium channel of the soil bacterium Streptomyces
lividans (van Dalen et al, 2002). Under deﬁned conditions,
this well-characterized inner membrane protein was shown
to induce translocation of the C6NBD-PG phospholipid ana-
logue through its transmembrane a-helices, albeit at long
incubation times (Kol et al, 2003). MraY is an integral
membrane enzyme that assembles Lipid I. As a combination
of synthesis and transport would likely be efﬁcient for the
cell, MraY may well be the transporter in addition to being a
synthesis enzyme. By virtue of its importance as a preserved
constituent of bacterial membranes and also in the transloca-
tion of secretory proteins, SecYEG would also be a candidate
Lipid II transporter. After inclusion of the puriﬁed KcsA,
MraY and SecYEG into LUVs containing NBD-Lipid II,
no signiﬁcant differences regarding the level of protected
ﬂuorescent pools were found between protein-free vesicles
(Figure 5B, dotted black trace), vesicles with KcsA
(Figure 5B, grey trace), vesicles with MraY (Supplementary
Figure S5A, red trace), vesicles with SecYEG (Supplementary
Figure S5B, red trace). This demonstrates that the topology of
Lipid II is not affected by the presence of these proteins.
A completely different picture emerged when FtsW-con-
taining proteoliposomes were assayed. With a protein to
phospholipids molar ratio of B1:20000, a reduction of
B70% in ﬂuorescence of NBD-Lipid II was visible, reﬂecting
that only 30% of the NBD-labelled Lipid II remained pro-
tected from quenching by dithionite, suggesting that FtsW
facilitated translocation of NBD-labelled Lipid II from the
inner to the outer leaﬂet (Figure 5B, black trace). An intri-
guing observation is the persistence of a pool of protected
NBD-labelled Lipid II, which can be explained as follows. The
reconstitution procedure allows for the generation of a pool
of NBD-Lipid II containing vesicles devoid of FtsW. Of these
vesicles, only 50% of NBD-Lipid II is accessible to dithionite
reduction. Therefore, the level of reduction by dithionite is
expected to be dependent on the amount of transporters in
the vesicle preparations, and the addition of more FtsW
should result in fewer transporter-less LUVs. Indeed, the
extent of quenching of ﬂuorescence was shown to be FtsW
concentration dependent, as measured from vesicles recon-
stituted with different amounts of FtsW (Figure 6). Yet, even
at the highest amount of FtsW, a pool of NBD-labelled Lipid II
remained protected from quenching by dithionite. This is best
explained by aggregation of FtsW during the reconstitution
procedure that is thereby not incorporated into the proteoli-
posomes and which would still allow for a signiﬁcant amount
of vesicles devoid of FtsW. These ﬁndings are consistent with
results reported previously for translocation by other trans-
porters of phospholipids and dolichol-linked oligosaccharides
across the yeast endoplasmic reticulum (Vehring et al,2 0 0 7 ;
Sanyal et al, 2008).
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Figure 5 FtsW induces transbilayer movement of NBD-Lipid II in
proteoliposomes. (A) Coomassie-stained SDS–PAGE gel analysis of
puriﬁed FtsW. The arrow at B37kDa points to the FtsW band.
(B) LUVs containing NBD-Lipid II symmetrically distributed be-
tween the inner and outer leaﬂets of the bilayer and solubilized with
Triton X-100 were reconstituted with no protein, the control protein
KcsA or FtsW following the procedure detailed in Materials and
methods. After addition of dithionite (1), a reduction of almost 50%
of the ﬂuorescence signal is displayed by protein-free vesicles and
proteoliposomes containing KscA. In contrast, B70% quenching is
obtained when FtsW-containing proteoliposomes were employed.
When 0.1% Triton X-100 was added (2) to permeabilize the
vesicles, a complete quenching of all the ﬂuorescence is achieved.
All measurements were carried out at 201C and are representative of
at least three independent experiments. A.U.: arbitrary units.
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The effect obtained with proteoliposomes containing FtsW
can be explained by two possibilities: (i) the presence of FtsW
allows Lipid II translocation across the membrane or (ii) can
be due to FtsW-dependent leakiness of the proteoliposomes
to dithionite. To exclude the latter possibility, we carried out
control experiments using NBD-labelled UDP-MurNAc-penta-
peptide that was present in the lumen of the vesicles. In all
combinations no signiﬁcant difference between FtsW and
KcsA-containing vesicles was detectable, revealing that the
proteoliposomes remained sealed under all tested conditions
(Supplementary Figure S6), and hence emphasizing the
involvement of FtsW in the transport of Lipid II.
Our results using dithionite quenching were additionally
conﬁrmed using the FRET-based assay. We reconstituted
vesicles in the absence of protein, with KcsA or FtsW.
Addition of vancomycin-TMR yielded a higher FRET signal
in the presence of FtsW than in the control situations;
protein-free vesicles and vesicles reconstituted with KcsA
(Figure 7). This result can be understood in the following
way. Whereas in vesicles devoid of transporter (no protein or
with KcsA), the vancomycin-TMR can bind to only half the
pool of NBD-Lipid II, in vesicles harbouring FtsW, the vanco-
mycin-TMR eventually binds to the most of the Lipid II pool
that is ﬂipped to the outer leaﬂet. Moreover, after subjecting
these proteoliposomes to quenching by dithionite on ice, at a
temperature that allows the reduction reaction but blocks
the translocation, prior to the addition of vancomycin-TMR
similar results were obtained (Supplementary Figure S7).
Thus, a much larger Lipid II pool is accessible for vancomycin
in the presence of FtsW, conﬁrming its role as a Lipid II
transporter.
Discussion
The enzymes involved in the assembly of cell wall peptido-
glycan have been known for decades. However, the protein
that transports the lipid-linked (peptidoglycan) precursors
across the cytoplasmic membrane was the last key step in
this fundamental process that remained to be identiﬁed.
Attempts to unravel this route have been hampered by the
unavailability of convenient assays, allowing for studying the
ﬂippase activity and the biochemical events of transport
experimentally. On the basis of ﬂuorescence studies to
assay the transport of NBD-Lipid II across bacterial inner
membrane vesicles and on biochemical evidence accumu-
lated from the reconstituted system, this work reveals that
FtsW is a Lipid II transporter. In view of the identiﬁcation of
FtsW as the transporter of peptidoglycan subunits, it is
anticipated that other members of SEDS family such as the
FtsW homologues, RodA and SpoVE, are also likely to
participate in the translocation of Lipid II during cell elonga-
tion and spore peptidoglycan synthesis in B. subtilis, respec-
tively. Moreover, our ﬁndings argue against the latest reports
that proposed MviN (MurJ) as the putative Lipid II ﬂippase
(Inoue et al, 2008; Ruiz, 2008). In this respect, our results are
consistent with the ﬁnding that was very recently reported,
describing that MviN homologues in B. subtilis are not
essential for growth and do not seem to have a role as the
ﬂippase of Lipid II (Fay and Dworkin, 2009). Furthermore,
FtsW was encountered among the preserved proteins, pre-
viously revealed by the bioinformatics search for candidates
for Lipid II ﬂippase (Ruiz, 2008). In spite of this, a role of this
protein as a Lipid II ﬂippase was not considered, as FtsW
was absent in the peptidoglycan-bearing Vesicomyosocious
okutanii (that does possess RodA), and two of its
homologues were present in the peptidoglycan-less
Mollicute Eubacterium dolichum DSM 3991 (Ruiz, 2008).
Yet, there are several examples of proteins speciﬁcally re-
quired for a deﬁned process; such as, peptidoglycan biosynth-
esis, in bacteria possessing a cell wall that are also
encountered in bacteria lacking this biosynthetic route. In
this regard, it is worthwhile to note the recent elaboration of
the existence of a functional and essential Lipid II biosynth-
esis pathway in the cell wall-less bacteria Chlamydia and
Wolbachia (Henrichfreise et al, 2009).
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Figure 7 Increased accessibility of Lipid II to vancomycin in
proteoliposomes containing FtsW. Vesicles without any protein
or reconstituted with the control protein KcsA or with FtsW were
prepared according to the procedure described before. FRET mea-
surements were then carried out at 141C after addition of vanco-
mycin-TMR. FtsW-containing vesicles display a much higher FRET
signal than the protein-free and KcsA-containing vesicles. All mea-
surements are representative of at least three independent experi-
ments. A.U.: arbitrary units.
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Figure 6 The effect of FtsW in facilitating the transbilayer move-
ment of Lipid II in model membranes is concentration dependent.
Proteoliposomes were reconstituted in the presence of FtsW at the
following protein/phospholipid molar ratio: 1:40000 (1), 1:20000
(2), 1:10000 (3) and 1:5000 (4). The assay was performed as
delineated under Figure 5. The percentage of quenching of ﬂuores-
cence is dependent on the concentration of FtsW used in the
reconstitution procedure. All measurements were carried out at
201C and are representative of at least three independent experi-
ments. A.U.: arbitrary units.
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synthesis, it is however not excluded that this protein might
also be involved in a different way, for example, by interact-
ing with other (redundant) proteins required for this process.
To conﬁrm that MviN has no direct role in transport of Lipid
II, we tested the effect of this protein in bacterial membrane
vesicles as well as in model membranes (Supplementary
Figures S8 and S9). In contrast to overexpression of
FtsW (Figure 3B), overexpression of MviN did not result in
enhanced transport of NBD-labelled Lipid II (Supplementary
Figure S8). Similarly, co-reconstitution of puriﬁed MviN
and Lipid II in vesicles did not lead to an increased accessi-
bility of NBD-Lipid II for dithionite (Supplementary
Figure S9), showing that this protein has no direct role in
Lipid II translocation.
Although the mechanism underlying the ﬂipping route
remains to be elucidated, the present work identiﬁes for the
ﬁrst time a speciﬁc protein as a transporter of complex sugars
across biological membranes. This process was previously
demonstrated to be independent of any metabolic energy.
Therefore, it is conceivable that the transport process occurs
through facilitated diffusion, allowing Lipid II to equilibrate
between the two leaﬂets of the inner membrane. As the
peptidoglycan synthesis was shown to occur very fast, the
transmembrane movement of Lipid II should at least match
this speed that was estimated to occur at a rate of
B5000moleculess
 1 (Sanyal and Menon, 2009). As ex-
pected, in our assays the translocation process was shown
to occur rapidly. The transbilayer movement of Lipid II was
accomplished within few seconds to minutes after addition of
dithionite or vancomycin, respectively. The time required for
the reduction reaction by dithionite and or binding of vanco-
mycin poses therefore a constraint for studying the kinetics of
the transport process.
The obvious difference in rate of transport between our
two assays points to the existence of a regulatory process in
the biological membranes that is absent in the reconstituted
system and that FtsW-mediated transmembrane transport is
not the rate-limiting step.
In this regard, it is worthwhile to note that, in the bacterial
membrane vesicles, not all of the synthesized NBD-labelled
Lipid II was transported. This can be deduced by comparing
the FRET signal or ratio of the acceptor/donor ﬂuorescence
(578/534nm) in Figure 2 (3.9, here all NBD-labelled Lipid II
molecules are bound to vancomycin-TMR) to the maximal
ratio obtained in Figure 3C (1.9 for membranes from FtsW
overproducing strain). This plateau level of translocation is
most likely caused by an obstruction of the transporter
channel by newly transported NBD-labelled Lipid II that is
bound by vancomycin-TMR. Hence, the maximal FRETsignal
in the translocation assay reﬂects the actual amount of
(active) transporters in the system, thus explaining the
increased FRET signal for membranes with increased levels
of FtsW and decreased FRET signal for membranes with
depleted levels of FtsW.
In addition to its necessity as an essential protein in cell
division, FtsW is present in virtually all eubacteria that
synthesize a peptidoglycan cell wall and has no counterpart
in humans. Therefore, revealing its speciﬁc function will not
only further our understanding of the fundamental cellular
processes involved in bacterial growth but may also prove
valuable in the design of novel antibiotics.
Materials and methods
Phospholipids and bacterial cell wall precursors
All phospholipids were purchased from Avanti Polar Lipids
(Alabaster, AL). Stock solutions were prepared in chloroform/
methanol (1:1, v/v) and stored under nitrogen at  201C.
Phospholipids concentration was determined with a lipid phos-
phorus assay according to Rouser et al, 1970. The lysine form of
UDP-MurNAc-pentapeptide was puriﬁed from Staphylococcus simu-
lans as previously described (Kohlrausch and Holtje, 1991). This
compound was labelled with NBD chloride at the lysine of the
pentapeptide moiety residue following the same procedure as
reported before for the labelling of UDP-MurNAc-pentapeptide with
pyrenesulphonylchloride (Breukink et al, 2003). The synthesis and
puriﬁcation of the cell wall precursor NBD-labelled Lipid II was
performed as described (Breukink et al, 2003; van Dam et al, 2007).
Undecaprenyl phosphate was extracted from Laurus nobilis leaves
(Breukink et al, 2003) and phosphorylated as described (Breukink
et al, 2003). All other chemicals were obtained from Sigma.
Synthesis of vancomycin-TMR
Fluorescently labelled vancomycin was used as the acceptor in the
FRET assay (see below). To this end, vancomycin was coupled via
its carboxyl-terminus to TMR (Molecular Probes). In brief, the
labelling procedure consisted of assembling a reaction comprising
1000nmol vancomycin HCl (MP Biomedicals), 250nmol TMR,
300nmol 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and
300nmol 1-hydroxy-7-azobenzotriazole in DMF in a total volume
of 250ml, followed by overnight incubation under nitrogen in the
dark at room temperature. The vacuum-desiccated mixture was
then dissolved in 60ml water/acetonitrile/triﬂuoro acetic acid
(82:18:0.09). After separation on a RP-C18 HPLC column, the
fractions containing labelled vancomycin were collected and
pooled. Using a rotary evaporator the residual acetonitrile
and triﬂuoro acetic acid were removed and the remaining sample
was dehydrated on a freeze dryer. The resulting dried material was
dissolved in 250ml water. The overall yield of the reaction was
estimated to be 54%.
Expression and puriﬁcation of recombinant proteins
The expression and puriﬁcation of His-tagged KcsAwere carried out
as described previously (van Dalen et al, 2002). His-tagged MraY
from B. subtilis was puriﬁed as published earlier (Bouhss et al,
2004). The strains and plasmids used in this study are listed in
Supplementary Table S1.
Puriﬁed His-tagged SecYEG from E. coli (Van der Does et al,
1998) was a generous gift from Dr Ilja Ku ¨sters and Prof Dr Arnold
Driessen (Molecular Microbiology, University of Groningen, The
Netherlands).
The E. coli strain used for the expression of MviN as well as
puriﬁed His-tagged MviN from E. coli (to be published elsewhere)
were a generous gift from Prof Dr Dominique Mengin-Lecreulx
(Institut de Biochimie et Biophysique Mole ´culaire et Cellulaire,
Universite ´ Paris-Sud, France).
The puriﬁcation of recombinant FtsW was carried out as follows:
E. coli strain C43(DE3) harbouring the plasmid pDML2400
(encoding N-terminal His6-FtsW) was grown at 371C in LB medium
supplemented with 50mg/ml of kanamycin to an OD600 of 0.6.
Expression of the proteins was induced with 1mM IPTG. Growth
was continued for 5h. Cells were collected by centrifugation and
resuspended in a buffer containing 50mM Tris–HCl, pH 8.0, 50mM
NaCl, 1mM PMSF and complete EDTA-free protease inhibitors
(Roche, Germany). The bacterial cells were lysed by passing
twice through a cell disruptor (pressure setting 2kbar) and
subsequently centrifuged for 10min 12000g at 41C. The membranes
were pelleted by centrifugation at 200000g for 45min at 41C, and
then resuspended and washed in a buffer comprising 20mM
Tris–HCl, pH 8.0, 500mM NaCl, 10% glycerol and complete EDTA-
free protease inhibitors. After centrifugation, the pellet was
resuspended in 50mM Hepes, pH 7.5, 500 NaCl and 10% glycerol.
To solubilize the membranes the resulting mixture was incubated
with 0.5% LAPAO (Anatrace) for 1h at 41C. The proteins, recovered
in the supernatant after centrifugation at 200000g for 45min at 41C,
were puriﬁed by Ni-afﬁnity chromatography.
The puriﬁcation procedure consisted of incubating the solubi-
lized membranes with 5ml of Ni Sepharose High Performance
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with 50mM Hepes, pH 7.5, 500mM NaCl, 10mM imidazole and
0.1% LAPAO. On-column detergent exchange was then carried out.
The column was extensively washed with a 50mM Hepes, pH 7.5,
300mM NaCl, 10% glycerol, 1mM n-dodecyl-b-D-maltopyranoside
(DDM, Anatrace) and 10mM imidazole buffer. The proteins were
eluted with a stepwise increasing concentration of imidazole
ranging from 20 to 250mM in a 50mM Hepes, pH 7.5, 300mM
NaCl and 1mM DDM buffer. His-tagged FtsW was recovered in
fractions eluting between 100 and 200mM imidazole. Fractions
containing FtsW were pooled and concentrated using Amicon ultra-
4 centrifugal ﬁlter devices 10K NMWL (Millipore) to remove
imidazole. The sample was then subjected to a second puriﬁcation
step using a Ni-charged HiTrap chelating column of 1ml. Washing
and eluting of the proteins were subsequently carried out as
described above. Integrity and purity of the protein was assessed by
SDS–PAGE and immunoblotting. The protein concentration of the
isolated His-tagged protein was determined with BCA reagent kit,
according to the manufacturer’s protocol (Pierce, Rockford, IL,
USA), and densitometry of the Coomassie Brilliant Blue stained gel
using bovine serum albumin as standard.
Dithionite reduction assay
Preparation of proteoliposomes. For the dithionite reduction assay,
LUVs containing ﬂuorescently labelled Lipid II were prepared. This
was achieved by mixing 60mol% DOPC, 25mol% DOPE, 15mol%
DOPG from stock solutions. For the incorporation of Lipid II, a
0.1mol% of NBD-Lipid II was added to the mixture. Lipids were
dried by nitrogen stream, followed by vacuum desiccation for 2h.
The obtained lipid ﬁlms were hydrated with a buffer composed of
10mM Hepes-KOH, pH 8, 100mM NaCl, 5mM KCl and 1mM
MgSO4 to a lipid–phosphate (LPi) concentration of B5mM.
Subsequently, the vesicle suspension was subjected to 10 cycles of
freezing and thawing. Finally, unilamellar vesicles were obtained
after 10 rounds of extrusion through 200nm membrane ﬁlters
(Anotop 10, Whatman, Maidstone UK).
Reconstitution of proteins into proteoliposomes. The proteolipo-
somes were incubated with proteins. For reconstitution of proteins
350ml LUVs (5mM LPi) were ﬁrst solubilized with 8mM Triton X-
100, followed by the addition of a puriﬁed protein. The ﬁnal
concentration of the proteins was adjusted to a protein–phospho-
lipid molar ratio of B1:20000. This was followed by incubation
with gentle agitation for 1h at 41C. Samples were then supple-
mented with 100mg/ml Bio-Beads SM-2 Adsorbent (Bio-Rad
Laboratories Inc.) to remove the detergent. After 2h of incubation
at 41C, another 100mg/ml fresh Bio-Beads suspension was added to
the micelle solution and a second incubation overnight at 41C was
undertaken. Thereafter, a third incubation with 100mg/ml fresh
Bio-Beads was performed for 2h. Subsequently, the vesicles were
collected by ultracentrifugation at 435000g for 30min and
resuspended in 200ml 10mM Hepes-KOH, pH 8, 100mM NaCl,
5mM KCl and 1mM MgSO4.
Flop and ﬂuorescence measurement. The in-to-out translocation
(ﬂop) of NBD-Lipid II in LUVs and proteoliposomes was measured
by determining the percentage of NBD ﬂuorescence that is not
available for reduction by 8mM sodium dithionite, added from a
1M stock solution in 1M Tris, pH 11 (Kol et al, 2001; van Dam et al,
2007). When required, excess of dithionite was removed by
supplementing the mixture with a molar excess of 20mM potassium
ferricyanide (III), (Sigma-Aldrich, Germany), added from a 1M
stock solution in water. After quenching, 10ml of a 10% (w/v)
solution of Triton X-100 in water was added to permeabilize the
membrane and make all remaining NBD-label available for
dithionite reduction.
Measurements were performed at 201C in 1.25ml buffer in a
quartz cuvette using an SLM Aminco SPF 500C ﬂuorimeter. The
excitation and emission wavelengths were adjusted to 481 and
534nm, respectively. Emission spectra were recorded between 500
and 620nm.
FRET-based translocation assay
Translocation of NBD-Lipid II in isolated E. coli membrane vesicles
was measured according to the method published by van Dam et al,
2007 with slight modiﬁcations. In this assay, FRET was used as a
means of measuring Lipid II transport across the cytoplasmic
membrane. To this end, RSO vesicles were isolated from various
E. coli strains as indicated and prepared in 50mM potassium
phosphate buffer (pH 7.5) containing 10mM NaCl and 1mM MgSO4
as described (Kol et al, 2001). NBD-UDP-MurNAc-pentapeptide
(250pmol) and UDP-GlcNAc (10nmol) were incorporated in the
membrane vesicles (125nmol lipid Pi) by performing two steps of
freezing and thawing on ice in a volume of 45ml 50mM potassium
phosphate buffer (pH 7.5) comprising 10mM NaCl and 1mM
MgSO4. This procedure resulted in the incorporation of 4% of the
NBD-UDP-MurNAc-pentapeptide and UDP-GlcNAc in the vesicles,
as determined using radiolabelled versions of the precursors. NBD-
Lipid II synthesis occurred during the incubation of the samples on
ice. After washing, the membrane pellet was resuspended into
1.25ml of the same buffer, and ﬂuorescence spectra were recorded
between 500 and 620nm in the presence or absence of 68pmol
vancomycin-TMR at 141C at different time points during 30min.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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